ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 45 filers reported holding ODONATE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $541,000 | -74.6% | 400,914 | -45.2% | 0.00% | – |
| Q3 2021 | $2,128,000 | -14.1% | 731,497 | +3.1% | 0.00% | – |
| Q2 2021 | $2,477,000 | -54.6% | 709,620 | -55.5% | 0.00% | – |
| Q1 2021 | $5,460,000 | -82.1% | 1,596,232 | +0.5% | 0.00% | -100.0% |
| Q4 2020 | $30,493,000 | +151.9% | 1,588,116 | +76.2% | 0.00% | – |
| Q3 2020 | $12,107,000 | -68.2% | 901,464 | +0.3% | 0.00% | -100.0% |
| Q2 2020 | $38,056,000 | +80.5% | 898,837 | +17.7% | 0.00% | +100.0% |
| Q1 2020 | $21,088,000 | -25.5% | 763,817 | -12.4% | 0.00% | 0.0% |
| Q4 2019 | $28,308,000 | +25.6% | 872,303 | +0.7% | 0.00% | 0.0% |
| Q3 2019 | $22,542,000 | +6.1% | 866,052 | +49.6% | 0.00% | 0.0% |
| Q2 2019 | $21,236,000 | +157.8% | 578,823 | +55.4% | 0.00% | – |
| Q1 2019 | $8,237,000 | +70.0% | 372,585 | +8.3% | 0.00% | – |
| Q4 2018 | $4,844,000 | -26.3% | 344,069 | +1.5% | 0.00% | – |
| Q3 2018 | $6,576,000 | -10.9% | 338,825 | +1.4% | 0.00% | – |
| Q2 2018 | $7,380,000 | +22.6% | 334,259 | +17.6% | 0.00% | – |
| Q1 2018 | $6,018,000 | – | 284,121 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 4,207,086 | $5,553,000 | 0.28% |
| Samsara BioCapital, LLC | 700,421 | $925,000 | 0.23% |
| Hennion & Walsh Asset Management, Inc. | 69,264 | $91,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 384,995 | $506,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 43,752 | $58,000 | 0.00% |
| SIMPLEX TRADING, LLC | 2,000 | $2,000 | 0.00% |
| Newbridge Financial Services Group, Inc. | 47 | $0 | 0.00% |
| BESSEMER GROUP INC | 230 | $0 | 0.00% |